GoodRx Holdings, Inc.GDRXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+41.4%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+41.4%/yr
vs -6.2%/yr prior
Acceleration
+47.7pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
2.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$184.36M+19.8%
2024$153.92M+41.4%
2023$108.82M+66.9%
2022$65.19M+35.8%
2021$48.00M+118.7%
2020$-257.11M-276.0%
2019$146.12M+73.2%
2018$84.35M+42.0%
2017$59.41M+112.1%
2016$28.01M-